hepatitis A vaccine pediatric/adolescent (HepA) 720 UNT in 0.5 ML Prefilled Syringe
- RxCUI
- 798481
- RxNorm name
- hepatitis A vaccine pediatric/adolescent (HepA) 720 UNT in 0.5 ML Prefilled Syringe
- Display name
- hepatitis A vaccine pediatric/adolescent (HepA) 720 UNT in 0.5 ML Prefilled Syringe
- Full name
- hepatitis A vaccine pediatric/adolescent (HepA) 720 UNT in 0.5 ML Prefilled Syringe
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:29
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 103475 | Havrix | Hepatitis A Vaccine | 351(a) | Rx | 2026-09-01 |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| f9499a4d-1288-4bd3-9d59-1d72092c38cd | hepatitis A vaccine pediatric/adolescent (HepA) 720 UNT in 0.5 ML Prefilled Syringe [PSN] · 0.5 ML hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML Prefilled Syringe [SCD] · hepatitis A vaccine (inactivated) strain HM175 720 UNT per 0.5 ML Prefilled Syringe [SY] | 3 | 33 | These highlights do not include all the information needed to use HAVRIX safely and effectively. See full prescribing information for HAVRIX. HAVRIX (Hepatitis A Vaccine) injectable suspension, for intramuscular use Initial U.S. Approval: 1995 | 20260514 |
| 7df68090-7e98-4b01-9c29-0b941a1c307d | hepatitis A vaccine pediatric/adolescent (HepA) 720 UNT in 0.5 ML Prefilled Syringe [PSN] · 0.5 ML hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML Prefilled Syringe [SCD] · hepatitis A vaccine (inactivated) strain HM175 720 UNT per 0.5 ML Prefilled Syringe [SY] | 3 | 13 | These highlights do not include all the information needed to use HAVRIX safely and effectively. See full prescribing information for HAVRIX. HAVRIX (Hepatitis A Vaccine) injectable suspension, for intramuscular use Initial U.S. Approval: 1995 | 20240625 |